Clinomics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 1,019,543 | 3.11% |
Institutions | 1,305,468 | 3.98% |
Individual Insiders | 3,342,610 | 10.2% |
General Public | 27,139,665 | 82.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,453,373 | ₩4.1b | 0% | no data | |||
1,305,468 | ₩2.2b | -20% | 0.13% | |||
1,019,543 | ₩1.7b | 0% | no data | |||
535,388 | ₩894.6m | -31.2% | no data | |||
159,675 | ₩266.8m | 0% | no data | |||
116,350 | ₩194.4m | 0% | no data | |||
54,793 | ₩91.6m | 0% | no data | |||
23,031 | ₩38.5m | 0% | no data |